Abstract
The addition of IFN-gamma to cultures of peripheral blood mononuclear cells (PBMCs) obtained from asymptomatic HIV-infected patients increased cell proliferation in response to HIV envelope synthetic peptides (Env), influenza A virus (VIRUS), and allogeneic lymphocytes (ALLO) but not to phytohaemagglutinin (PHA) stimulation. F(Ab)2 fragments of IgG purified from the sera of HIV-seropositive patients specifically interfered with IFN-gamma-induced cell proliferation in response to recall antigens. Neutralization of the lymphokine activity was found to be sustained by specific IFN-gamma antibodies. Data obtained demonstrate that IFN-gamma can restore the cell-mediated immunity of a number of asymptomatic HIV+ individuals in vitro, while IFN-gamma antibodies present in sera of patients with AIDS interfere with the activity of the lymphokine.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acquired Immunodeficiency Syndrome / immunology*
-
Amino Acid Sequence
-
Antibodies, Monoclonal / immunology*
-
HIV Antibodies / immunology
-
HIV Envelope Protein gp120 / pharmacology
-
HIV Infections / immunology*
-
HIV Seronegativity / immunology*
-
Humans
-
Immunity, Cellular
-
Immunoglobulin Fab Fragments / immunology
-
Immunoglobulin G / immunology
-
Influenza A virus / immunology
-
Interferon-gamma / immunology*
-
Isoantigens / immunology
-
Lymphocyte Activation / drug effects
-
Lymphocyte Activation / immunology
-
Molecular Sequence Data
-
Peptide Fragments / pharmacology
-
Recombinant Proteins
-
T-Lymphocytes / immunology*
Substances
-
Antibodies, Monoclonal
-
HIV Antibodies
-
HIV Envelope Protein gp120
-
Immunoglobulin Fab Fragments
-
Immunoglobulin G
-
Isoantigens
-
Peptide Fragments
-
Recombinant Proteins
-
Interferon-gamma